Загрузка...
Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others
Colorectal cancer (CRC) is a heterogeneous disease for which the treatment backbone has primarily been cytotoxic chemotherapy. With better understanding of the involved molecular mechanisms, it is now known that there are a number of epigenetic and genetic events, which are involved in CRC pathogene...
Сохранить в:
| Опубликовано в: : | J Gastrointest Oncol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056251/ https://ncbi.nlm.nih.gov/pubmed/27747085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.07.03 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|